Advertisement
YOU ARE HERE: LAT HomeCollectionsAmgen

Business Briefing / Courts

Part of Amgen verdict is upheld

September 16, 2009|Times Wire Reports

Amgen Inc. won an appeals court ruling that helps preserve its $5.6-billion-a-year franchise in anemia medicines from competition from Roche Holding's Mircera drug.

An appeals court upheld part of a patent-infringement verdict won by Amgen, while ordering a new trial on other aspects. Roche can challenge the scope of an order that prevents U.S. sales of Mircera until at least 2012, the court ruled.

Advertisement
Los Angeles Times Articles
|
|
|